ATE359076T1 - Mittel gegen juckreiz - Google Patents
Mittel gegen juckreizInfo
- Publication number
- ATE359076T1 ATE359076T1 AT97912539T AT97912539T ATE359076T1 AT E359076 T1 ATE359076 T1 AT E359076T1 AT 97912539 T AT97912539 T AT 97912539T AT 97912539 T AT97912539 T AT 97912539T AT E359076 T1 ATE359076 T1 AT E359076T1
- Authority
- AT
- Austria
- Prior art keywords
- remedies
- itching
- morphinian
- antipruritic
- opiate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Magnetic Record Carriers (AREA)
- Steroid Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Elimination Of Static Electricity (AREA)
- Table Equipment (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP31347696 | 1996-11-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE359076T1 true ATE359076T1 (de) | 2007-05-15 |
Family
ID=18041771
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03001740T ATE263563T1 (de) | 1996-11-25 | 1997-11-21 | Mittel gegen juckreiz |
AT97912539T ATE359076T1 (de) | 1996-11-25 | 1997-11-21 | Mittel gegen juckreiz |
AT03001739T ATE291429T1 (de) | 1996-11-25 | 1997-11-21 | Mittel gegen juckreiz |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03001740T ATE263563T1 (de) | 1996-11-25 | 1997-11-21 | Mittel gegen juckreiz |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03001739T ATE291429T1 (de) | 1996-11-25 | 1997-11-21 | Mittel gegen juckreiz |
Country Status (15)
Country | Link |
---|---|
US (2) | US6174891B1 (de) |
EP (5) | EP1327444B1 (de) |
KR (1) | KR100557801B1 (de) |
CN (3) | CN1535687A (de) |
AT (3) | ATE263563T1 (de) |
AU (1) | AU738743B2 (de) |
CA (1) | CA2244256C (de) |
DE (3) | DE69732868T2 (de) |
DK (1) | DK0897726T3 (de) |
ES (3) | ES2236630T3 (de) |
NO (1) | NO316309B1 (de) |
NZ (1) | NZ331001A (de) |
PT (1) | PT897726E (de) |
TW (1) | TW542838B (de) |
WO (1) | WO1998023290A1 (de) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5763445A (en) * | 1996-03-08 | 1998-06-09 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
ATE384532T1 (de) * | 1996-12-24 | 2008-02-15 | Elkhoury George F | Topische anwendung von opioiden, wie morphin, zur linderung von juckreiz und hautkrankheiten sowie hautreizungen |
WO1999003459A1 (en) * | 1997-07-14 | 1999-01-28 | Adolor Corporation | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
JP3211027B2 (ja) * | 1998-11-13 | 2001-09-25 | 丸石製薬株式会社 | カプサイシン含有外用剤 |
WO2001014382A1 (fr) * | 1999-08-23 | 2001-03-01 | Toray Industries, Inc. | Analgesiques contenant des derives sel d'ammonium quaternaire comme principe actif |
WO2001014383A1 (fr) * | 1999-08-24 | 2001-03-01 | Toray Industries, Inc. | Remedes contre les douleurs neuropathiques et modeles animaux de douleurs neuropathiques |
WO2001074819A1 (fr) * | 2000-04-03 | 2001-10-11 | Toray Industries, Inc. | Agents analgesiques contenant des derives de n-oxyde de morphinane en tant que principe actif |
JP2002249442A (ja) * | 2001-02-21 | 2002-09-06 | Fumakilla Ltd | アレルギー減感作治療薬 |
ES2319265T3 (es) * | 2001-03-30 | 2009-05-06 | Toray Industries, Inc. | Farmacos para el sindrome de piernas inquietas. |
US6617308B2 (en) | 2001-04-30 | 2003-09-09 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons |
US7294688B2 (en) | 2001-04-30 | 2007-11-13 | Nanogen Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons |
JP4239592B2 (ja) * | 2001-05-08 | 2009-03-18 | 東レ株式会社 | 敗血症治療剤 |
US6844438B2 (en) | 2001-08-15 | 2005-01-18 | Mclean Hospital Corporation | N-substituted derivatives of morphinan and uses thereof |
CA2464528A1 (en) * | 2001-11-02 | 2003-05-15 | Elan Corporation, Plc | Pharmaceutical composition |
ES2390052T3 (es) | 2002-03-29 | 2012-11-06 | Santen Pharmaceutical Co., Ltd. | Agonistas del receptor opioide kappa que comprende un derivado de 2-fenilbenzotiazolina |
WO2004026262A2 (en) * | 2002-09-23 | 2004-04-01 | Verion, Inc. | Abuse-resistant pharmaceutical compositions |
PT1543010E (pt) * | 2002-09-25 | 2007-07-26 | Euro Celtique Sa | Hidromorfonas n-substituídas e a sua utilização |
CA2561509C (en) | 2004-03-30 | 2012-08-28 | Toray Industries, Inc. | Anti-itching agent |
US7704522B2 (en) * | 2004-09-08 | 2010-04-27 | Clyde Morgan | Topical medicament |
CA2580694A1 (en) * | 2004-09-23 | 2006-03-30 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
US20080045610A1 (en) * | 2004-09-23 | 2008-02-21 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
US20060159748A1 (en) * | 2004-12-23 | 2006-07-20 | Rajesh Jain | Oral immediate release formulation of a poorly water-soluble active substance |
US7453122B2 (en) * | 2005-02-08 | 2008-11-18 | Taiwan Semiconductor Manufacturing Co., Ltd. | SOI MOSFET device with reduced polysilicon loading on active area |
CN101137658B (zh) * | 2005-03-10 | 2011-06-08 | 东丽株式会社 | 用于与多发性硬化症伴随的搔痒的止痒剂 |
RU2397173C2 (ru) | 2005-04-06 | 2010-08-20 | Торей Индастриз, Инк. | Кристаллические производные морфинана и способ их получения |
TW200806294A (en) * | 2005-11-09 | 2008-02-01 | Toray Industries | Therapeutic or prophylactic agent for functional intestinal injury |
AU2006328765B2 (en) * | 2005-12-21 | 2012-01-12 | Toray Industries, Inc. | Antitussive agent |
AU2007297827B2 (en) * | 2006-09-20 | 2012-09-20 | Mallinckrodt Llc | Preparation of substituted morphinan-6-ones and salts and intermediates thereof |
CA2680205C (en) * | 2007-03-06 | 2015-06-30 | Mallinckrodt Inc. | Process for the preparation of quaternary n-alkyl morphinan alkaloid salts |
US9040726B2 (en) | 2007-03-06 | 2015-05-26 | Mallinckrodt Llc | Process for the preparation of quaternary N-alkyl morphinan alkaloid salts |
WO2008133297A1 (ja) | 2007-04-24 | 2008-11-06 | Toray Industries, Inc. | ジスキネジアの治療または予防剤 |
JP5099127B2 (ja) * | 2007-04-26 | 2012-12-12 | 東レ株式会社 | 4,5−エポキシモルヒナン誘導体を含有する安定な固形製剤 |
US8183256B2 (en) * | 2007-06-22 | 2012-05-22 | Toray Industries, Inc. | Remedy or preventive for integration dysfunction syndrome |
RU2440117C1 (ru) * | 2007-10-05 | 2012-01-20 | Торэй Индастриз, Инк. | Терапевтическое средство для улучшения свойств кожи, включающее в качестве действующего ингредиента производное морфинана или любую из его фармакологически приемлемых кислотно-аддитивных солей |
WO2009138734A2 (en) * | 2008-05-14 | 2009-11-19 | Serentis Limited | Use of opioid compounds in peripheral pain, wound healing and scar formation |
JP6027315B2 (ja) * | 2008-05-27 | 2016-11-16 | マリンクロッド エルエルシー | ノルモルフィナンの調製のための方法および化合物 |
US9458109B2 (en) | 2008-09-03 | 2016-10-04 | Mallinckrodt Llc | Substituted berbines and processes for their synthesis |
US8946419B2 (en) | 2009-02-23 | 2015-02-03 | Mallinckrodt Llc | (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives |
EP2398806A1 (de) * | 2009-02-23 | 2011-12-28 | Mallinckrodt LLC | (+)-morphinanium-n-oxide und verfahren zu ihrer herstellung |
CN102325775A (zh) * | 2009-02-23 | 2012-01-18 | 马林克罗特公司 | (+)-6-羟基-吗啡喃或(+)-6-氨基-吗啡喃衍生物 |
US8436174B2 (en) * | 2009-02-23 | 2013-05-07 | Mallinckrodt Llc | (+)-morphinanium quaternary salts and processes for their production |
WO2011009020A2 (en) | 2009-07-16 | 2011-01-20 | Mallinckrodt Inc. | Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers |
TWI477505B (zh) * | 2010-01-29 | 2015-03-21 | Toray Industries | 膽管疾病之治療或預防劑 |
EP2671585B1 (de) | 2011-01-31 | 2016-07-13 | Toray Industries, Inc. | (-)-17-(Cyclopropylmethyl)-3,14ß-Dihydroxy-4,5a-Epoxy-6ß-[N-Methyl-trans-3-(3-Furyl)acrylamido]Morphinan zur Verwendung bei der Behandlung oder Vorbeugung von Krebskachexie |
JP2014526467A (ja) | 2011-09-08 | 2014-10-06 | マリンクロッド エルエルシー | 中間体の単離なしでのアルカロイドの調製 |
JP6064252B2 (ja) * | 2012-01-19 | 2017-01-25 | 三笠製薬株式会社 | そう痒症改善経皮吸収貼付剤 |
US20140179727A1 (en) | 2012-12-14 | 2014-06-26 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
BR112015013984A2 (pt) * | 2012-12-14 | 2017-07-11 | Trevi Therapeutics Inc | métodos para o tratamento de prurido |
US8637538B1 (en) | 2012-12-14 | 2014-01-28 | Trevi Therapeutics, Inc. | Methods for treatment of pruritis |
US8987289B2 (en) | 2012-12-14 | 2015-03-24 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
WO2016052617A1 (ja) * | 2014-09-30 | 2016-04-07 | 国立大学法人筑波大学 | ナルフラフィン含有局所適用製剤 |
TW201707703A (zh) * | 2015-06-04 | 2017-03-01 | Tokai Capsule Co Ltd | 軟膠囊劑 |
CN106866688B (zh) * | 2015-12-10 | 2019-05-03 | 山东诚创医药技术开发有限公司 | 一种纳呋拉啡的精制方法 |
ES2970294T3 (es) * | 2016-03-21 | 2024-05-27 | Trevi Therapeutics Inc | Tratamiento del prurito urémico |
CN108883185B (zh) * | 2016-12-06 | 2021-10-08 | 江苏恒瑞医药股份有限公司 | 一种κ阿片受体激动剂在制备治疗法尼醇X受体激动剂引起的瘙痒的药物中的用途 |
US20210015813A1 (en) | 2018-03-08 | 2021-01-21 | Victoria Link Ltd. | Treatment of demyelinating diseases |
CN118477079A (zh) | 2018-07-23 | 2024-08-13 | 特雷维治疗股份有限公司 | 慢性咳嗽、呼吸急促和呼吸困难的治疗 |
AU2020250468A1 (en) * | 2019-03-29 | 2021-11-04 | Kinki University | Use of T-type calcium channel blocker for treating pruritus |
WO2022004788A1 (ja) | 2020-06-30 | 2022-01-06 | 東レ株式会社 | 代謝異常を伴う疾患又は症候群における筋力低下症状の改善剤又は予防剤 |
KR20240035395A (ko) | 2021-06-14 | 2024-03-15 | 스코르피온 테라퓨틱스, 인코퍼레이티드 | 암 치료에 사용할 수 있는 요소 유도체 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU196376B (en) * | 1985-05-23 | 1988-11-28 | Sandoz Ag | Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds |
US5021413B1 (en) * | 1988-08-24 | 1994-12-13 | Sankyo Co | Analgesic thiomorpholins, their preparation, and pharmaceutical compositions containing them |
EP0398720A3 (de) * | 1989-05-18 | 1991-07-03 | Glaxo Group Limited | Piperazin-Derivate |
ATE172201T1 (de) * | 1992-01-23 | 1998-10-15 | Toray Industries | Morphinan-derivate und medizinische verwendung |
JPH06122677A (ja) * | 1992-08-28 | 1994-05-06 | Sankyo Co Ltd | 光学活性なカルボン酸アミド誘導体 |
DE69413933T2 (de) * | 1993-06-30 | 1999-04-08 | Toray Industries, Inc., Tokio/Tokyo | Antitussiva |
JPH09504018A (ja) * | 1993-10-20 | 1997-04-22 | ザ ブーツ カンパニー ピーエルシー | 抗掻痒薬としてのイブプロフェンおよびフルルビプロフェン |
IT1273751B (it) | 1994-02-11 | 1997-07-10 | Smithkline Beecham Farma | Derivati azaciclici |
US5760023A (en) | 1997-07-14 | 1998-06-02 | Adolor Corporation | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
WO1999003459A1 (en) * | 1997-07-14 | 1999-01-28 | Adolor Corporation | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
-
1997
- 1997-11-21 DE DE69732868T patent/DE69732868T2/de not_active Expired - Lifetime
- 1997-11-21 PT PT97912539T patent/PT897726E/pt unknown
- 1997-11-21 ES ES03001739T patent/ES2236630T3/es not_active Expired - Lifetime
- 1997-11-21 NZ NZ331001A patent/NZ331001A/xx not_active IP Right Cessation
- 1997-11-21 EP EP03001739A patent/EP1327444B1/de not_active Expired - Lifetime
- 1997-11-21 AT AT03001740T patent/ATE263563T1/de not_active IP Right Cessation
- 1997-11-21 EP EP97912539A patent/EP0897726B1/de not_active Expired - Lifetime
- 1997-11-21 EP EP03001740A patent/EP1310255B1/de not_active Expired - Lifetime
- 1997-11-21 AT AT97912539T patent/ATE359076T1/de active
- 1997-11-21 DE DE69737592T patent/DE69737592T2/de not_active Expired - Lifetime
- 1997-11-21 WO PCT/JP1997/004267 patent/WO1998023290A1/ja active IP Right Grant
- 1997-11-21 US US09/117,052 patent/US6174891B1/en not_active Expired - Lifetime
- 1997-11-21 EP EP03001723A patent/EP1312361A1/de not_active Withdrawn
- 1997-11-21 CA CA002244256A patent/CA2244256C/en not_active Expired - Lifetime
- 1997-11-21 EP EP03001741A patent/EP1310251A1/de not_active Withdrawn
- 1997-11-21 KR KR1019980705696A patent/KR100557801B1/ko active Protection Beyond IP Right Term
- 1997-11-21 CN CNA200310123373XA patent/CN1535687A/zh active Pending
- 1997-11-21 ES ES03001740T patent/ES2215158T3/es not_active Expired - Lifetime
- 1997-11-21 AU AU49683/97A patent/AU738743B2/en not_active Expired
- 1997-11-21 CN CNB2003101225979A patent/CN1291717C/zh not_active Expired - Lifetime
- 1997-11-21 ES ES97912539T patent/ES2285733T3/es not_active Expired - Lifetime
- 1997-11-21 DK DK97912539T patent/DK0897726T3/da active
- 1997-11-21 DE DE69728585T patent/DE69728585T2/de not_active Expired - Lifetime
- 1997-11-21 AT AT03001739T patent/ATE291429T1/de not_active IP Right Cessation
- 1997-11-21 CN CNB97193343XA patent/CN1180844C/zh not_active Expired - Lifetime
- 1997-11-24 TW TW086117591A patent/TW542838B/zh active
-
1998
- 1998-07-24 NO NO19983431A patent/NO316309B1/no not_active IP Right Cessation
-
2000
- 2000-07-13 US US09/615,540 patent/US6316461B1/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE291429T1 (de) | Mittel gegen juckreiz | |
PT800519E (pt) | Compostos moduladores de receptores de esteroides e metodos | |
AU2002213336A1 (en) | Substituted heterocyclic compounds for treating multidrug resistance | |
ES2155601T3 (es) | Compuestos de benzolactama sustituidos como antagonistas de la sustancia p. | |
ID18883A (id) | Pesaing 5-ht 1f | |
DE60133029D1 (de) | Mittel zur prävention oder behandlung von psoriasi | |
ES2184127T3 (es) | Derivados de sulfamato anticonvulsivos utiles para el tratamiento de la obesidad. | |
IL138476A0 (en) | Method for treating pharmaceutical compositions by special use of anti-oxidant | |
EA200300566A1 (ru) | Применение cci-779 в качестве противоопухолевого средства | |
TR199801255T2 (xx) | Vitronektin resept�r antagonistleri. | |
ATE231872T1 (de) | Thiazolopyrimidinderivate | |
DE69928655D1 (de) | Substituierte porphyrine | |
ATE256671T1 (de) | 2-phenyl-substituierte 1-(n-phenylaminoalkyl)- piperazin-derivate | |
PT1117403E (pt) | Antagonistas de mglurs para o tratamento da dor e ansiedade | |
ATE304530T1 (de) | Substituierte 1,5-dihydropyrrol-2-on-derivate wirksam als nmda-rezeptor-antagonisten für die behandlung von schmerzzuständen | |
EA199900912A1 (ru) | Фармацевтические средства | |
BR9807883A (pt) | Compostos de tetraidropirido | |
IL152097A0 (en) | Use of pyrazole derivatives for treating infertility | |
PT977716E (pt) | Utilizacao de alcoois como aditivos para rebocos e/ou argamassas | |
BR0206917A (pt) | Uso de antagonistas de mglur5 para o tratamento de condições prurìticas | |
TR200100240T2 (tr) | Anksiyete bozukluklarının tedavisi | |
BRPI0507987A (pt) | métodos e compostos moduladores receptor de glicocorticóide | |
ATE267194T1 (de) | Medikamente geeignet zur behandlung von proliferativen erkrankungen | |
MXPA05009428A (es) | Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas. | |
IL139144A0 (en) | Mycobacterial inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0897726 Country of ref document: EP |